Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chanchal Goswami

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Cancer Research and Therapeutics|November 14, 2007
Post-irradiation angiosarcoma of boneSrabani Mittal, Chanchal Goswami, Nandini Kanoria, et al.
Journal of Cancer Research and Therapeutics|February 17, 2016
Primary Ewing's sarcoma of the squamous part of temporal bone in a young girl treated with adjuvant volumetric arc therapyMoujhuri Nandi, Jibak Bhattacharya, Suchanda Goswami, et al.
South Asian Journal of Cancer|August 25, 2021
Indian Expert Opinion on Cancer Care during COVID-19 PandemicAshok K Vaid, Hemant Malhotra, Raja Thirumalairaj, et al.
JCO Global Oncology|June 8, 2021
Prevalence of <i>BRCA1</i> and <i>BRCA2</i> Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional StudySudeep Gupta, Senthil Rajappa, Suresh Advani, et al.
Indian Journal of Cancer|January 3, 2018
Advanced therapeutic options and importance of rebiopsy in epidermal growth factor receptor-tyrosine kinase inhibitor-progressed nonsmall cell lung carcinoma patients: An expert opinionSuresh H Advani, Hemant Malhotra, Raju Titus Chacko, et al.
The Lancet. Oncology|December 24, 2011
Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled studyWalter H Gotlieb, Frederic Amant, Suresh Advani, et al.
Frontiers in Oncology|April 16, 2020
Expert Consensus on Effective Management of Chemotherapy-Induced Nausea and Vomiting: An Indian PerspectiveAshok K Vaid, Sudeep Gupta, Dinesh C Doval, et al.
Oncotargets and Therapy|June 27, 2014
Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small-cell lung cancer: a multicenter, randomized, open-label Phase II studyK Govind Babu, Kumar Prabhash, Ashok K Vaid, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|March 8, 2014
Histopathological pattern of lymphomas and clinical presentation and outcomes of diffuse large B cell lymphoma: A multicenter registry based study from IndiaRamesh B V Nimmagadda, Raghunadharao Digumarti, Reena Nair, et al.
Asia-Pacific Journal of Clinical Oncology|November 27, 2012
A multicenter phase II randomized study of Cremophor-free polymeric nanoparticle formulation of paclitaxel in women with locally advanced and/or metastatic breast cancer after failure of anthracyclineAnantbhushan A Ranade, Poonamalle P Bapsy, Shona Nag, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Cancer Research and Therapeutics|November 14, 2007
Post-irradiation angiosarcoma of boneSrabani Mittal, Chanchal Goswami, Nandini Kanoria, et al.
Journal of Cancer Research and Therapeutics|February 17, 2016
Primary Ewing's sarcoma of the squamous part of temporal bone in a young girl treated with adjuvant volumetric arc therapyMoujhuri Nandi, Jibak Bhattacharya, Suchanda Goswami, et al.
South Asian Journal of Cancer|August 25, 2021
Indian Expert Opinion on Cancer Care during COVID-19 PandemicAshok K Vaid, Hemant Malhotra, Raja Thirumalairaj, et al.
JCO Global Oncology|June 8, 2021
Prevalence of <i>BRCA1</i> and <i>BRCA2</i> Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional StudySudeep Gupta, Senthil Rajappa, Suresh Advani, et al.
Indian Journal of Cancer|January 3, 2018
Advanced therapeutic options and importance of rebiopsy in epidermal growth factor receptor-tyrosine kinase inhibitor-progressed nonsmall cell lung carcinoma patients: An expert opinionSuresh H Advani, Hemant Malhotra, Raju Titus Chacko, et al.
The Lancet. Oncology|December 24, 2011
Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled studyWalter H Gotlieb, Frederic Amant, Suresh Advani, et al.
Frontiers in Oncology|April 16, 2020
Expert Consensus on Effective Management of Chemotherapy-Induced Nausea and Vomiting: An Indian PerspectiveAshok K Vaid, Sudeep Gupta, Dinesh C Doval, et al.
Oncotargets and Therapy|June 27, 2014
Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small-cell lung cancer: a multicenter, randomized, open-label Phase II studyK Govind Babu, Kumar Prabhash, Ashok K Vaid, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|March 8, 2014
Histopathological pattern of lymphomas and clinical presentation and outcomes of diffuse large B cell lymphoma: A multicenter registry based study from IndiaRamesh B V Nimmagadda, Raghunadharao Digumarti, Reena Nair, et al.
Asia-Pacific Journal of Clinical Oncology|November 27, 2012
A multicenter phase II randomized study of Cremophor-free polymeric nanoparticle formulation of paclitaxel in women with locally advanced and/or metastatic breast cancer after failure of anthracyclineAnantbhushan A Ranade, Poonamalle P Bapsy, Shona Nag, et al.
Pageof 2